Pharmacokinetics, Antiviral Activity, and Safety of Rilpivirine in Pregnant Women with HIV-1 Infection: Results of a Phase 3b, Multicenter, Open-Label Study.

about

Pharmacokinetics, Antiviral Activity, and Safety of Rilpivirine in Pregnant Women with HIV-1 Infection: Results of a Phase 3b, Multicenter, Open-Label Study.

Item

http://www.wikidata.org/entity/Q47553402

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Pharmacokinetics, Antiviral Ac ...... Multicenter, Open-Label Study.

@en

Pharmacokinetics, Antiviral Ac ...... Multicenter, Open-Label Study.

@nl

type

Item

label

Pharmacokinetics, Antiviral Ac ...... Multicenter, Open-Label Study.

@en

Pharmacokinetics, Antiviral Ac ...... Multicenter, Open-Label Study.

@nl

prefLabel

Pharmacokinetics, Antiviral Ac ...... Multicenter, Open-Label Study.

@en

Pharmacokinetics, Antiviral Ac ...... Multicenter, Open-Label Study.

@nl

P1476

Pharmacokinetics, Antiviral Ac ...... Multicenter, Open-Label Study.

@en

P2093

Carmen Zorrilla

http://www.w3.org/2001/XMLSchema#string

Ceyhun Bicer

http://www.w3.org/2001/XMLSchema#string

Herta M Crauwels

http://www.w3.org/2001/XMLSchema#string

Kimberley Brown

http://www.w3.org/2001/XMLSchema#string

Olayemi Osiyemi

http://www.w3.org/2001/XMLSchema#string

Salih Yasin

http://www.w3.org/2001/XMLSchema#string

Vera Hillewaert

http://www.w3.org/2001/XMLSchema#string

P2860

Rilpivirine versus efavirenz in HIV-1-infected subjects receiving emtricitabine/tenofovir DF: pooled 96-week data from ECHO and THRIVE Studies.

Total and unbound darunavir pharmacokinetics in pregnant women infected with HIV-1: results of a study of darunavir/ritonavir 600/100 mg administered twice daily.

Efavirenz pharmacokinetics during the third trimester of pregnancy and postpartum.

Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach.

Suboptimal nevirapine steady-state pharmacokinetics during intrapartum compared with postpartum in HIV-1-seropositive Ugandan women.

Pharmacokinetics of Rilpivirine in HIV-Infected Pregnant Women.

Etravirine Pharmacokinetics in HIV-Infected Pregnant Women.

Plasma protein binding of drugs in pregnancy and in neonates.

Antiretroviral Pharmacokinetics in Pregnant Women.

Pharmacokinetics of once-daily darunavir/ritonavir in HIV-1-infected pregnant women.

P2888

s40121-017-0184-8

P304

147-159

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40121-017-0184-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29335895

http://www.w3.org/2001/XMLSchema#string

P932

5840103

http://www.w3.org/2001/XMLSchema#string